Precision Biosciences Announces First-in-Human Study for Chronic Hepatitis B Treatment
Precision BioSciences, a clinical-stage gene editing company, has announced a significant advancement in its quest to cure chronic hepatitis...
Jon Napitupulu
Predicting First-Line Incontinence Treatment Success in Women
Researchers have developed a potential machine learning model that could personalize treatments for female pelvic floor disorders, specifically urinary...
Prevnar 20® Recommended for Adults 50+ by ACIP
The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practice (ACIP) has recommended expanding the...
Nanoknife® System’s Long-Term Effects Studied in New Trial
AngioDynamics, a medical technology company specializing in vascular health and cancer treatment, has initiated a global registry study to...
OPM-101 RIPK2 Inhibitor Shows Strong Safety, No Cardiac Toxicity in Phase 1 Study
Oncodesign Precision Medicine (OPM) has announced the successful completion of its Phase 1 clinical trial for OPM-101, an orally...
Medable: Top Patient Engagement Trailblazer by Everest Group
Medable, a leading clinical trial technology platform, has been recognized as a Trailblazer in Everest Group’s first-ever “Clinical Trial...
FDA Approves Pfizer’s Abrysvo RSV Vaccine for Adults
Pfizer recently received approval from the U.S. Food and Drug Administration (FDA) for ABRYSVO®, its respiratory syncytial virus (RSV)...
Gilead Unveils Latest Liver Disease Research at AASLD 2024
Gilead Sciences is set to present over 40 research abstracts at The Liver Meeting® 2024, highlighting its commitment to...
New Study Links Antidepressant Use to Muscle Health and Cardiometabolic Risk
A recent study from AMRA Medical and the University of Oslo sheds light on the impact of antidepressants, specifically...
ArteraAI Prostate Test Now Accessible in CA
Artera, a company specializing in AI-powered cancer tests, has received a license from the California Department of Public Health,...